Critics Question Effectiveness Of Medicines Patent Pool In Improving Access To Drugs
SciDev.Net: Merck’s HIV patent agreement ignites monopoly criticism
“Pharma giant Merck has become the latest drug company to share intellectual property rights with a U.N.-backed patent pool for HIV medicines, but critics have told SciDev.Net it is ‘a false solution to a real problem’…” (Kennedy, 3/16).
The KFF Daily Global Health Policy Report summarized news and information on global health policy from hundreds of sources, from May 2009 through December 2020. All summaries are archived and available via search.